37648000: Clindamycin phosphate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Clindamycin phosphate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Clindamycin phosphate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Pyrrolidine\Clindamycin phosphate

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Pyrrolidine\Clindamycin phosphate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Clindamycin phosphate	Is a	Product containing clindamycin (medicinal product)	false	Inferred relationship	Some
Clindamycin phosphate	Is a	Clindamycin (substance)	false	Inferred relationship	Some
Clindamycin phosphate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Clindamycin (substance)	true	Inferred relationship	Some
Clindamycin phosphate	Is a	Pyrrolidine	true	Inferred relationship	Some
Clindamycin phosphate	Is a	Antibacterial	true	Inferred relationship	Some
Clindamycin phosphate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Benzoyl peroxide + clindamycin phosphate 50mg/10mg gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clindamycin phosphate	Inferred relationship	Some
Benzoyl peroxide + clindamycin phosphate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clindamycin phosphate	Inferred relationship	Some
Clindamycin phosphate 300mg/2mL injection solution 2mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clindamycin phosphate	Inferred relationship	Some
Product containing precisely benzoyl peroxide 50 milligram/1 gram and clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clindamycin phosphate	Inferred relationship	Some
clindamycin 300 mg/2 ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clindamycin phosphate	Inferred relationship	Some
Benzoyl peroxide + clindamycin phosphate 50mg/10mg gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clindamycin phosphate	Inferred relationship	Some
clindamycin 1,2 % + tretinoin 0,025 % gel til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clindamycin phosphate	Inferred relationship	Some
clindamycinphosphat 900 mg/6 ml injektionsvæske, opløsning, hætteglas a 6 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clindamycin phosphate	Inferred relationship	Some
clindamycinphosphat 150 mg/ml injektionsvæske, opløsning, ampul a 4 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clindamycin phosphate	Inferred relationship	Some
clindamycinphosphat 150 mg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clindamycin phosphate	Inferred relationship	Some
clindamycinphosphat 150 mg/ml injektionsvæske, opløsning, ampul a 6 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Clindamycin phosphate	Inferred relationship	Some
Product containing precisely clindamycin (as clindamycin phosphate) 100 milligram/1 each conventional release vaginal pessary (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely benzoyl peroxide 50 milligram/1 gram and clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous lotion	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely clindamycin (as clindamycin phosphate) 300 milligram/2 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely clindamycin (as clindamycin phosphate) 600 milligram/4 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Clindamycin phosphate 20 mg/mL vaginal cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Clindamycin phosphate	Inferred relationship	Some	1
Clindamycin phosphate 20 mg/mL vaginal cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
clindamycinphosphat 1 % lotion	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clindamycin phosphate	Inferred relationship	Some	1
clindamycinphosphat 1 % lotion	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Clindamycin phosphate	Inferred relationship	Some	1
clindamycinphosphat 1 % opløsning til topikal anvendelse	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Clindamycin phosphate	Inferred relationship	Some	1
clindamycinphosphat 1 % opløsning til topikal anvendelse	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Clindamycin phosphate	Inferred relationship	Some	1
Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Clindamycin phosphate	Inferred relationship	Some	1
Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Clindamycin phosphate	Inferred relationship	Some	1
Clindamycin (as clindamycin phosphate) 20 mg/g vaginal cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely clindamycin (as clindamycin phosphate) 12 milligram/1 milliliter conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Product containing precisely clindamycin (as clindamycin phosphate) 6 milligram/1 milliliter conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Clindamycin (as clindamycin phosphate) 150 mg/mL solution for infusion and/or injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Clindamycin (as clindamycin phosphate) 150 mg/mL solution for infusion	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous emulsion	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Clindamycin phosphate	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
62799019	Clindamycin phosphate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
62800015	Clindamicin phosphate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
769539013	Clindamycin phosphate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2692531000005118	Clindamycinphosphat	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)